Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Drug repositioning (often used interchangeably with drug repurposing) is re-investigating existing drugs that failed approval for new therapeutic indications. Drug repurposing on the other hand is the application of already approved drugs and compounds to treat a different disease.
This report elaborates the market size, market characteristics, and market growth of the Drug Repurposing industry, and breaks down according to the type, application, and consumption area of Drug Repurposing. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.
In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Drug Repurposing in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.
Key players in the global Drug Repurposing market covered in Chapter 13:
Pfizer Inc.
Hoffmann-La Roche
Johnson & Johnson
Abbott Healthcare
Mylan Inc.
Sandoz
Novartis AG
Teva Pharmaceuticals
IBM
In Chapter 6, on the basis of types, the Drug Repurposing market from 2015 to 2025 is primarily split into:
Orally Drug
Intravenously Drug
In Chapter 7, on the basis of applications, the Drug Repurposing market from 2015 to 2025 covers:
Central Nervous Disorders
Cardiovascular Disorders
Oncology
Metabolic
Autoimmune
Other
Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 Drug Repurposing Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years
2 Drug Repurposing Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer
3 Drug Repurposing Market Forces
3.1 Global Drug Repurposing Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment
4 Drug Repurposing Market - By Geography
4.1 Global Drug Repurposing Market Value and Market Share by Regions
4.1.1 Global Drug Repurposing Value ($) by Region (2015-2020)
4.1.2 Global Drug Repurposing Value Market Share by Regions (2015-2020)
4.2 Global Drug Repurposing Market Production and Market Share by Major Countries
4.2.1 Global Drug Repurposing Production by Major Countries (2015-2020)
4.2.2 Global Drug Repurposing Production Market Share by Major Countries (2015-2020)
4.3 Global Drug Repurposing Market Consumption and Market Share by Regions
4.3.1 Global Drug Repurposing Consumption by Regions (2015-2020)
4.3.2 Global Drug Repurposing Consumption Market Share by Regions (2015-2020)
5 Drug Repurposing Market - By Trade Statistics
5.1 Global Drug Repurposing Export and Import
5.2 United States Drug Repurposing Export and Import (2015-2020)
5.3 Europe Drug Repurposing Export and Import (2015-2020)
5.4 China Drug Repurposing Export and Import (2015-2020)
5.5 Japan Drug Repurposing Export and Import (2015-2020)
5.6 India Drug Repurposing Export and Import (2015-2020)
5.7
6 Drug Repurposing Market - By Type
6.1 Global Drug Repurposing Production and Market Share by Types (2015-2020)
6.1.1 Global Drug Repurposing Production by Types (2015-2020)
6.1.2 Global Drug Repurposing Production Market Share by Types (2015-2020)
6.2 Global Drug Repurposing Value and Market Share by Types (2015-2020)
6.2.1 Global Drug Repurposing Value by Types (2015-2020)
6.2.2 Global Drug Repurposing Value Market Share by Types (2015-2020)
6.3 Global Drug Repurposing Production, Price and Growth Rate of Orally Drug (2015-2020)
6.4 Global Drug Repurposing Production, Price and Growth Rate of Intravenously Drug (2015-2020)
7 Drug Repurposing Market - By Application
7.1 Global Drug Repurposing Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Drug Repurposing Consumption by Applications (2015-2020)
7.1.2 Global Drug Repurposing Consumption Market Share by Applications (2015-2020)
7.2 Global Drug Repurposing Consumption and Growth Rate of Central Nervous Disorders (2015-2020)
7.3 Global Drug Repurposing Consumption and Growth Rate of Cardiovascular Disorders (2015-2020)
7.4 Global Drug Repurposing Consumption and Growth Rate of Oncology (2015-2020)
7.5 Global Drug Repurposing Consumption and Growth Rate of Metabolic (2015-2020)
7.6 Global Drug Repurposing Consumption and Growth Rate of Autoimmune (2015-2020)
7.7 Global Drug Repurposing Consumption and Growth Rate of Other (2015-2020)
8 North America Drug Repurposing Market
8.1 North America Drug Repurposing Market Size
8.2 United States Drug Repurposing Market Size
8.3 Canada Drug Repurposing Market Size
8.4 Mexico Drug Repurposing Market Size
8.5 The Influence of COVID-19 on North America Market
9 Europe Drug Repurposing Market Analysis
9.1 Europe Drug Repurposing Market Size
9.2 Germany Drug Repurposing Market Size
9.3 United Kingdom Drug Repurposing Market Size
9.4 France Drug Repurposing Market Size
9.5 Italy Drug Repurposing Market Size
9.6 Spain Drug Repurposing Market Size
9.7 The Influence of COVID-19 on Europe Market
10 Asia-Pacific Drug Repurposing Market Analysis
10.1 Asia-Pacific Drug Repurposing Market Size
10.2 China Drug Repurposing Market Size
10.3 Japan Drug Repurposing Market Size
10.4 South Korea Drug Repurposing Market Size
10.5 Southeast Asia Drug Repurposing Market Size
10.6 India Drug Repurposing Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market
11 Middle East and Africa Drug Repurposing Market Analysis
11.1 Middle East and Africa Drug Repurposing Market Size
11.2 Saudi Arabia Drug Repurposing Market Size
11.3 UAE Drug Repurposing Market Size
11.4 South Africa Drug Repurposing Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market
12 South America Drug Repurposing Market Analysis
12.1 South America Drug Repurposing Market Size
12.2 Brazil Drug Repurposing Market Size
12.3 The Influence of COVID-19 on South America Market
13 Company Profiles
13.1 Pfizer Inc.
13.1.1 Pfizer Inc. Basic Information
13.1.2 Pfizer Inc. Product Profiles, Application and Specification
13.1.3 Pfizer Inc. Drug Repurposing Market Performance (2015-2020)
13.2 Hoffmann-La Roche
13.2.1 Hoffmann-La Roche Basic Information
13.2.2 Hoffmann-La Roche Product Profiles, Application and Specification
13.2.3 Hoffmann-La Roche Drug Repurposing Market Performance (2015-2020)
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Basic Information
13.3.2 Johnson & Johnson Product Profiles, Application and Specification
13.3.3 Johnson & Johnson Drug Repurposing Market Performance (2015-2020)
13.4 Abbott Healthcare
13.4.1 Abbott Healthcare Basic Information
13.4.2 Abbott Healthcare Product Profiles, Application and Specification
13.4.3 Abbott Healthcare Drug Repurposing Market Performance (2015-2020)
13.5 Mylan Inc.
13.5.1 Mylan Inc. Basic Information
13.5.2 Mylan Inc. Product Profiles, Application and Specification
13.5.3 Mylan Inc. Drug Repurposing Market Performance (2015-2020)
13.6 Sandoz
13.6.1 Sandoz Basic Information
13.6.2 Sandoz Product Profiles, Application and Specification
13.6.3 Sandoz Drug Repurposing Market Performance (2015-2020)
13.7 Novartis AG
13.7.1 Novartis AG Basic Information
13.7.2 Novartis AG Product Profiles, Application and Specification
13.7.3 Novartis AG Drug Repurposing Market Performance (2015-2020)
13.8 Teva Pharmaceuticals
13.8.1 Teva Pharmaceuticals Basic Information
13.8.2 Teva Pharmaceuticals Product Profiles, Application and Specification
13.8.3 Teva Pharmaceuticals Drug Repurposing Market Performance (2015-2020)
13.9 IBM
13.9.1 IBM Basic Information
13.9.2 IBM Product Profiles, Application and Specification
13.9.3 IBM Drug Repurposing Market Performance (2015-2020)
14 Market Forecast - By Regions
14.1 North America Drug Repurposing Market Forecast (2020-2025)
14.2 Europe Drug Repurposing Market Forecast (2020-2025)
14.3 Asia-Pacific Drug Repurposing Market Forecast (2020-2025)
14.4 Middle East and Africa Drug Repurposing Market Forecast (2020-2025)
14.5 South America Drug Repurposing Market Forecast (2020-2025)
15 Market Forecast - By Type and Applications
15.1 Global Drug Repurposing Market Forecast by Types (2020-2025)
15.1.1 Global Drug Repurposing Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Drug Repurposing Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Drug Repurposing Market Forecast by Applications (2020-2025)
List of Tables and Figures
Figure Drug Repurposing Picture
Table Drug Repurposing Key Market Segments
Figure Study and Forecasting Years
Figure Global Drug Repurposing Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Drug Repurposing Value ($) and Growth Rate (2015-2020)
Table Global Drug Repurposing Value ($) by Countries (2015-2020)
Table Global Drug Repurposing Value Market Share by Regions (2015-2020)
Figure Global Drug Repurposing Value Market Share by Regions in 2019
Figure Global Drug Repurposing Production and Growth Rate (2015-2020)
Table Global Drug Repurposing Production by Major Countries (2015-2020)
Table Global Drug Repurposing Production Market Share by Major Countries (2015-2020)
Figure Global Drug Repurposing Production Market Share by Regions in 2019
Figure Global Drug Repurposing Consumption and Growth Rate (2015-2020)
Table Global Drug Repurposing Consumption by Regions (2015-2020)
Table Global Drug Repurposing Consumption Market Share by Regions (2015-2020)
Figure Global Drug Repurposing Consumption Market Share by Regions in 2019
Table Global Drug Repurposing Export Top 3 Country 2019
Table Global Drug Repurposing Import Top 3 Country 2019
Table United States Drug Repurposing Export and Import (2015-2020)
Table Europe Drug Repurposing Export and Import (2015-2020)
Table China Drug Repurposing Export and Import (2015-2020)
Table Japan Drug Repurposing Export and Import (2015-2020)
Table India Drug Repurposing Export and Import (2015-2020)
Table Global Drug Repurposing Production by Types (2015-2020)
Table Global Drug Repurposing Production Market Share by Types (2015-2020)
Figure Global Drug Repurposing Production Share by Type (2015-2020)
Table Global Drug Repurposing Value by Types (2015-2020)
Table Global Drug Repurposing Value Market Share by Types (2015-2020)
Figure Global Drug Repurposing Value Share by Type (2015-2020)
Figure Global Orally Drug Production and Growth Rate (2015-2020)
Figure Global Orally Drug Price (2015-2020)
Figure Global Intravenously Drug Production and Growth Rate (2015-2020)
Figure Global Intravenously Drug Price (2015-2020)
Table Global Drug Repurposing Consumption by Applications (2015-2020)
Table Global Drug Repurposing Consumption Market Share by Applications (2015-2020)
Figure Global Drug Repurposing Consumption Share by Application (2015-2020)
Figure Global Central Nervous Disorders Consumption and Growth Rate (2015-2020)
Figure Global Cardiovascular Disorders Consumption and Growth Rate (2015-2020)
Figure Global Oncology Consumption and Growth Rate (2015-2020)
Figure Global Metabolic Consumption and Growth Rate (2015-2020)
Figure Global Autoimmune Consumption and Growth Rate (2015-2020)
Figure Global Other Consumption and Growth Rate (2015-2020)
Figure North America Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Table North America Drug Repurposing Consumption by Countries (2015-2020)
Table North America Drug Repurposing Consumption Market Share by Countries (2015-2020)
Figure North America Drug Repurposing Consumption Market Share by Countries (2015-2020)
Figure United States Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure Canada Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure Mexico Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Table Europe Drug Repurposing Consumption by Countries (2015-2020)
Table Europe Drug Repurposing Consumption Market Share by Countries (2015-2020)
Figure Europe Drug Repurposing Consumption Market Share by Countries (2015-2020)
Figure Germany Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure France Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure Italy Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure Spain Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Drug Repurposing Consumption by Countries (2015-2020)
Table Asia-Pacific Drug Repurposing Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Drug Repurposing Consumption Market Share by Countries (2015-2020)
Figure China Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure Japan Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure South Korea Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure India Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Drug Repurposing Consumption by Countries (2015-2020)
Table Middle East and Africa Drug Repurposing Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Drug Repurposing Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure UAE Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure South Africa Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Figure South America Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Table South America Drug Repurposing Consumption by Countries (2015-2020)
Table South America Drug Repurposing Consumption Market Share by Countries (2015-2020)
Figure South America Drug Repurposing Consumption Market Share by Countries (2015-2020)
Figure Brazil Drug Repurposing Market Consumption and Growth Rate (2015-2020)
Table Pfizer Inc. Company Profile
Table Pfizer Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2015-2020
Table Hoffmann-La Roche Company Profile
Table Hoffmann-La Roche Production, Value, Price, Gross Margin 2015-2020
Figure Hoffmann-La Roche Production and Growth Rate
Figure Hoffmann-La Roche Value ($) Market Share 2015-2020
Table Johnson & Johnson Company Profile
Table Johnson & Johnson Production, Value, Price, Gross Margin 2015-2020
Figure Johnson & Johnson Production and Growth Rate
Figure Johnson & Johnson Value ($) Market Share 2015-2020
Table Abbott Healthcare Company Profile
Table Abbott Healthcare Production, Value, Price, Gross Margin 2015-2020
Figure Abbott Healthcare Production and Growth Rate
Figure Abbott Healthcare Value ($) Market Share 2015-2020
Table Mylan Inc. Company Profile
Table Mylan Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Mylan Inc. Production and Growth Rate
Figure Mylan Inc. Value ($) Market Share 2015-2020
Table Sandoz Company Profile
Table Sandoz Production, Value, Price, Gross Margin 2015-2020
Figure Sandoz Production and Growth Rate
Figure Sandoz Value ($) Market Share 2015-2020
Table Novartis AG Company Profile
Table Novartis AG Production, Value, Price, Gross Margin 2015-2020
Figure Novartis AG Production and Growth Rate
Figure Novartis AG Value ($) Market Share 2015-2020
Table Teva Pharmaceuticals Company Profile
Table Teva Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Teva Pharmaceuticals Production and Growth Rate
Figure Teva Pharmaceuticals Value ($) Market Share 2015-2020
Table IBM Company Profile
Table IBM Production, Value, Price, Gross Margin 2015-2020
Figure IBM Production and Growth Rate
Figure IBM Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Drug Repurposing Market Forecast Production by Types (2020-2025)
Table Global Drug Repurposing Market Forecast Production Share by Types (2020-2025)
Table Global Drug Repurposing Market Forecast Value ($) by Types (2020-2025)
Table Global Drug Repurposing Market Forecast Value Share by Types (2020-2025)
Table Global Drug Repurposing Market Forecast Consumption by Applications (2020-2025)
Table Global Drug Repurposing Market Forecast Consumption Share by Applications (2020-2025)
Research Methodology:
Drug Repurposing Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|